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UbiquinoneCoq5 catalyzes the onlyC-methylation involved in the biosynthesis of coenzymeQ (Qor ubiquinone) inhumans and
yeast Saccharomyces cerevisiae. As one of eleven polypeptides required for Q production in yeast, Coq5 has also been
shown to assemble with the multi-subunit complex termed the CoQ-synthome. In humans, mutations in several
COQ genes cause primary Q deﬁciency, and a decrease in Q biosynthesis is associatedwithmitochondrial, cardiovas-
cular, kidney and neurodegenerative diseases. In this study, we characterize the human COQ5 polypeptide and ex-
amine its complementation of yeast coq5 point andnullmutants.We show that human COQ5RNA is expressed in all
tissues and that the COQ5polypeptide is associatedwith themitochondrial innermembrane on thematrix side. Pre-
viouswork in yeast has shown that pointmutationswithin or adjacent to conserved COQ5methyltransferasemotifs
result in a loss of Coq5 function but not Coq5 steady state levels. Here, we show that stabilization of the CoQ-
synthomewithin coq5pointmutants or by over-expression of COQ8 in coq5nullmutants permits the humanCOQ5ho-
molog to partially restore coq5mutant growth on respiratory media and Q6 content. Immunoblotting against the
human COQ5 polypeptide in isolated yeast mitochondria shows that the human Coq5 polypeptide migrates in two-
dimensional blue-native/SDS-PAGE at the samehighmolecularmass as other yeast Coqproteins. The results presented
suggest that human and Escherichia coli Coq5 homologs expressed in yeast retain C-methyltransferase activity but are
capable of rescuing the coq5 yeast mutants only when the CoQ-synthome is assembled.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Coenzyme Q (ubiquinone or Q) is an essential lipophilic electron
carrier found within the mitochondrial inner membrane of eukaryotes
and the plasma membrane of many prokaryotes. Q is composed of a
polyisoprenoid “tail” that anchors it to the lipid membrane, and a
benzoquinone “head” that confers the abilities to shuttle electrons
from Complexes I and II to Complex III [1,2]. Q also acts as a cofactor
of uncoupling proteins and several mitochondrial dehydrogenases,
and in its reduced or hydroquinone form can quench lipid radical
species as an antioxidant [3,4].
The biosynthesis of the isoprenoid tail derives from either the
mevalonate or 1-deoxy-D-xylulose-5-phosphate pathways [5], with
the number of isoprene units varying in different species: six in
Saccharomyces cerevisiae, eight in Escherichia coli, and ten in humans.
In S. cerevisiae, the hexaprenyl diphosphate tail is attached to either
4-hydroxybenzoic acid (4HB) or para-aminobenzoic acid (pABA),
both of which have been shown to serve as aromatic ring precursors
in S. cerevisiae Q6 biosynthesis [6,7].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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biosynthesis, several of which encode proteins associated with the
mitochondrial inner membrane in a multi-subunit complex termed
the CoQ-synthome [8]. In the absence or deﬁciency of any one of these
genes, Q6 is not made and growth on medium containing a non-
fermentable carbon source is not possible; the presence of each Coq poly-
peptide is essential for the assembly of the Coq polypeptide complex
and for the proper function of each individual enzyme [9]. The over-
expression of COQ8, which encodes a putative regulatory kinase, has
been shown to restore steady state levels of several Coq polypeptides
[10] and the assembly of the high molecular mass CoQ-synthome [8].
In humans, decreased levels of Q10 are associatedwithmitochondri-
al, cardiovascular, kidney and neurodegenerative diseases [3,11]. Muta-
tions in COQ genes cause primary Q10 deﬁciency (OMIM #607426), one
of the few treatable mitochondrial disorders; in fact some affected
patients respond well to oral Q10 supplementation [12]. COQ genes are
highly conserved throughout evolution, and several human COQ genes
have complemented the corresponding yeast coq null mutant [11,13].
Previously, we have shown that expression of human ADCK3 (a yeast
Coq8 ortholog) fused with an N-terminal yeast mitochondrial leader
sequence rescued the growth of yeast coq8 null mutants and restored
de novo Q biosynthesis [14].
In this study, we report the cloning and functional characterization of
thehumanortholog of yeastCOQ5 and test its ability to complement yeast
coq5 point and null mutants. Coq5 catalyzes the only C-methylation
involved in the synthesis of Q6 in yeast [15]. Previous work in yeast has
shown that certain point mutations within or adjacent to conserved
COQ5methyltransferase motifs result in a loss of Coq5 methyltransferase
function, but mutants harboring these alleles (coq5-2, coq5-5) still retain
steady state levels of Coq5 protein [15,16]. Complementation of these
yeast point mutants with ubiE, an E. coli COQ5 homolog, restored respira-
tion and C-methyltransferase activity [16]. Here, we examine the function
of human COQ5, and show that expression of human COQ5 in yeast
mutants identiﬁes the functional conservation of the yeast and
human Q biosynthetic pathways, with implications for the diagnosis
and treatment of Q10 deﬁciencies in patients.2. Material and methods
2.1. Yeast strains and growth media
S. cerevisiae strains used in this study are listed in Table 1. Media
were prepared as described [17], and included: YPD (2% glucose, 1%
yeast extract, 2% peptone), YPGal (2% galactose, 1% yeast extract, 2%
peptone, 0.1% glucose), and YPG (3% glycerol, 1% yeast extract, 2%
peptone). Synthetic dextrose/minimal medium (SD, SD–Ura, and SD–
Ura–Leu) consisted of 0.18% yeast nitrogen base without amino acids,
2% dextrose, 0.14% NaH2PO4, and 0.5% (NH4)2SO4, and amino acids
(minus uracil or leucine for selective media) were added at ﬁnal con-
centrations as described in [15]. Drop-out media with dextrose (DOD)
lacking folate and para-amino benzoic acid and with proper amino
acid selectionwere prepared as described in [18]. Platemedia contained
2% bacto agar.Table 1
Genotype and source of yeast strains.
Strain Genotype Source or
reference
W303-1A MAT a ade2-1 his3-1,15 leu2-3,112
trp1-1 ura3-1
R. Rothsteina
W303ΔCOQ5 MAT a ade2-1 his3-1,15 leu2-3,112
trp1-1 ura3-1 coq5::HIS3
[15]
CH83-B3 MAT α ade2-1 coq5-2 his3-1,15 ura3-1 [16]
CH316-6B MAT α coq5-5 trp1-1 ura3-1 [16]
a Dr. Rodney Rothstein, Department of Human Genetics, Columbia University.2.2. Identiﬁcation of human COQ5
The human COQ5 gene (hCOQ5) cDNA sequence was identiﬁed by
screening the Expressed Sequence Tag (EST) database with the tBLASTn
algorithm (www.ncbi.nlm.nih.gov/blast) and the yeast protein sequence
as bait [19].
2.3. Plasmid construction
Plasmids used in this study are listed in Table 2. Human COQ5 was
ampliﬁed from cDNA obtained from human skin ﬁbroblasts [20] using
primers COQ5F and COQ5-1077R. PCR products were cloned in pCRII
TOPO (Invitrogen), and the high copy pYES2.1V5His yeast expression
vectors (Invitrogen). The COQ5 insert from pCRIITOPO-COQ5 was then
cloned into the centromeric pCM189 vector (EUROSCARF) [21]. Yeast
COQ5 (yCOQ5) was ampliﬁed from genomic DNA obtained from a
wild-type BY4741 strain using standard protocols and cloned into the
same vectors. Ampliﬁcation primers and conditions for all reactions
are shown in Table S1. The hybrid yeast–human COQ5 (yhCOQ5) gene
was obtained by amplifying a 5′ segment of yCOQ5, corresponding to
the mitochondrial targeting region (encoding aa 1–54; with primers
yCOQ5F and hybridCOQ5R) and the 3′ of human COQ5 (encoding aa
56–327; with primers hybridCOQ5F and COQ5-1037R). The two PCR
products were joined with a sequential PCR protocol [22].
To generate the COQ5-GFP fusion gene, the human COQ5 coding re-
gion (devoid of the termination codon) was ampliﬁed from pCRIITOPO-
COQ5 with primers containing HindIII and PstI restriction sites, digested
with HindIII and Pst1, and cloned into the pEGFP-N1 vector (Clontech)
digested with the same enzymes. Finally a myc-tag was added to the
C-terminus of hCOQ5 by PCR with primers COQ5F and COQ5mycR
(Table S1) and cloned into the pCDNA3.1V5HisTOPO vector (Invitrogen)
to yield pCOQ5-myc. All plasmid-constructs were sequenced to conﬁrm
the presence of the inserted DNA segments and to ascertain they were
free of errors.
2.4. Northern blot and RACE
Theprobe for Northern blot analysiswas obtained byEcoRI digestion
of pCRII TOPO-COQ5 and was labeled and puriﬁed as described in [19]
and hybridized to a commercial membrane (FirstChoice Human Blot 1
membrane–Ambion) containing 2 μg/lane of poly(A) + RNA from ten
human tissues, previously used as described [23] and stripped. Radioac-
tivity was detected with a Storm PhosphoImager (Molecular Dynamics,
Sunnyvale, CA, USA) after an overnight exposure. The 5′ and 3′ termini
of COQ5 transcripts were characterized by RACE (Rapid Ampliﬁcation of
cDNA Ends), a protocol that has been detailed elsewhere [19]. RNA was
extracted from cultured skinﬁbroblasts and fromHeLa cells. Primers are
reported in Table S1.
2.5. Localization of human COQ5 polypeptide in HeLa and HEK cells
The COQ5-GFP construct was used to transfect HeLa cells stably
expressingmitochondrial Red Florescent Protein (mtRFP) as previously
reported [20]. Procedures for mitochondrial isolation, proteinase K
protection assays, and carbonate extractionwere performed as described
[24]. Antibodies used are described in Table 3. Tagged versions of COQ5
were employed since our anti-COQ5 antibody detected only very faint
signals in cultured cells.
2.6. Immunoprecipitation of hCOQ5 from cultured cells
HEK 293 cells were co-transfectedwith the pCOQ5-myc and pCOQ4-
V5, and were harvested after 48 h and mitochondria were isolated
as above. About 3–4 mg of mitochondria were resuspended in 1 ml of
lysis buffer (150 mM NaCl; 10 mM Tris/HCl pH 7,4; 1 mM EDTA; 0.5%
Triton X-100; protease and phosphatase inhibitors) and incubated
Table 2
Plasmids.
Plasmids Relevant genes/markers Source or
reference
Yeast vectors
pyCOQ5 pCM189 with S. cerevisiae COQ5,
low copy
This work
phCOQ5 pCM189 with human COQ5,
low copy
This work
pyhCOQ5 pCM189 with the ﬁrst 55 amino acids
of human COQ5 replaced with the ﬁrst
54 amino acids of S. cerevisiae Coq5
This work
pYES-hCOQ5 pYES2.1V5His TOPOwith human
COQ5 high copy
This work
pUE3 pQM with E. coli ubiE; low copy [29]
p4HN5 (hcCOQ8) pRS426 with yeast ABC1/COQ8;
high copy
C. He a
pRS316 (vector) pRS316; low copy Addgene
Human vectors
pCOQ4-V5 Human COQ4-V5 fusion cloned
in pCDNA3.1TOPO
[20]
pCOQ5-V5 Human COQ5-V5 fusion cloned
in pCDNA3.1TOPO
This work
pCOQ5-myc Human COQ5-myc fusion cloned
in pCDNA3.1TOPO
This work
pCOQ5-GFP Human COQ5-GFP fusion cloned
in pEGFPN1 (Clontech)
This work
a Cuiwen H. He, Department of Chemistry and Biochemistry, UCLA.
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4 °C. An antibody-protein A-Sepharose 50% slurry was obtained by
crosslinking anti-V5, anti-myc antibodies (or the preimmune serum),
and incubated with 500 μl of the mitochondrial lysate overnight at 4 °C
with rotation. The immune-complex was washed with lysis buffer 0.1%
Triton X-100 and PBS (Life Technologies). The immune-precipitated pro-
teins were eluted with SDS-Laemmli buffer without β-mercaptoethanol
and heated for 10 min at 95 °C. The supernatant was collected, β-
mercaptoethanol was added to a ﬁnal concentration of 4%, heated again,
and subjected to SDS-PAGE. Proteins were transferred to membranes,
which were then probed with either anti-V5 or anti-myc antibodies.2.7. Functional complementation of the yeast coq5 mutant
Yeast transformations with the plasmids described in Table 2 were
performed with the PEG-lithium acetate method [25]. Transformed
yeast strains were selected and maintained in SD–Ura or SD–Ura–Leu
medium. For plate dilution assays, each strain was cultured overnight
in synthetic dextrosemediumwith proper amino acid selection. Optical
densities (A600 nm) of harvested cellswere adjusted to 0.2, and 2 μl of 1:5Table 3
Description and source of antibodies.
Antibody Source
Atp2 Carla. M. Koehlera
Coq5 (yeast) [16]
hCOQ5 (human) Santa Cruz Biotechnology
Coq9 [9]
GRP75 Santa Cruz
OPA1 BD Biosciences
OAT Abcam
Porin Mitoscience
SDHA Molecular Probes
TOM20 Santa Cruz
myc Sigma
V5 Invitrogen
a Dr. Carla. M. Koehler, Department of Chemistry and Biochemistry,
UCLA.serial dilutions were spotted onto YPG, YPD, and SD plate media, corre-
sponding to a ﬁnal A600 nm of 0.2, 0.04, 0.008, 0.0016, and 0.00032.
2.8. Lipid extraction and quantiﬁcation of Q6 by HPLC and tandem mass
spectrometry
To analyze Q6 content, yeast cells were seeded in SD with proper
amino acid selection at 0.2 OD/ml and collected after 3.5 to 4 h during
log phase (a total of 15–30 A600 nm were collected). Lipid extraction
and quantiﬁcation of Q6 in yeast cell lipid extracts were determined
by HPLC/MS–MS as described [6,10]. Q4 was used as internal standard
(expected ﬁnal concentration, 1 pmol/μl upon analysis). For de
novo Q6 labeling experiments, yeast were grown to log phase in SD
medium with proper selection and then seeded at 0.07 OD/ml into
DOD medium with proper amino acid selection supplemented with
8 μg/ml 13C6-pABA or 13C6-4HB (Cambridge Isotopes). Cultures were
grown for 10 h to late log phase, and lipid extraction and quantiﬁcation
of 13C6–Q6 was determined by HPLC/MS–MS as described [6,10].
2.9. Preparation of mitochondria from yeast
The yeast strains were grown in selective media to log phase. An
aliquot of the log phase culture was seeded into 600 ml YPGal + 0.1%
dextrose to a ﬁnal density of 0.05 OD600 nm and incubated with shaking
(250 rpm, 30 °C). The cells were harvested atOD600 nmbetween 2 and 3.
The puriﬁed mitochondria were isolated as described [18,26] in the
presence of 1× EDTA-free protease inhibitor (Roche) and 1:100 phos-
phatase inhibitor cocktail sets I and II (Calbiochem). Pure mitochondria
were ﬂash frozen in liquid nitrogen and stored at−80 °C. The protein
concentration was measured with a bicinchoninic acid assay with
bovine serum albumin as standard (Thermo Scientiﬁc).
2.10. Two-dimensional blue-native SDS/PAGE
Aliquots of puriﬁed mitochondria (200 μg protein) were solubilized
in 50 μl of 1.2% digitonin (Biosynth AG), 1× protease inhibitor (Roche),
1:100 phosphatase inhibitor cocktail sets I and II (Calbiochem) and 1×
NativePAGE sample buffer (Invitrogen). Samples were incubated on
ice for 1 h and mixed by pipetting up and down every 10 min. The
soluble supernatant fraction was separated from the insoluble pellet
by centrifugation in a Beckman Airfuge (100,000 ×g, 10 min, chilled
rotor). NativePAGE 5% G-250 sample additive (Invitrogen) was added
to the supernatant from 200 μg of digitonin-solubilized mitochondria
(50 μl) to a ﬁnal concentration of 2.5%. BN-PAGE was performed as
described in NativePAGE user manual with NativePAGE 4–16% Bis–Tris
gel 1.0 mm × 10 wells (Invitrogen). First dimension gel slices were
soaked in heated 2× SDS sample buffer for 20 min before loading onto
pre-cast 10% SDS-polyacrylamide gels. Proteins were transferred to
Immobilon-P transfer membrane (Millipore), and blocked in 1% skim
milk, phosphate-buffered saline, and 0.1% Tween-20 (phosphate buff-
ered saline, pH 7.4, is composed of 0.141 M NaCl, 1.2 mM NaH2PO4,
and 8.1 mMNa2HPO4). Membranes were treated with the following pri-
mary antibodies (Table 3): human Coq5, 1:2500, Coq5, 1:5000, Coq9,
1:1000; Atp2, 1:4000. Goat anti-rabbit secondary antibodies conjugated
to horseradish peroxidase (Calbiochem)were used at a 1:10,000 dilution
and visualized using the Alpha Innotech FluorChem FC2 Imaging System.
3. Results
3.1. Identiﬁcation and genetic characterization of human COQ5
The gene encoding human COQ5 spans to 26 kb on chromosome
12q24.31 and is comprised of seven exons. The open reading frame is
981 nucleotides long encoding a predicted 327 amino acid protein
which contains a putative mitochondrial targeting sequence and shares
45% identity and 60% similarity with the yeast protein (excluding the
AB
Fig. 1.Biosynthesis ofQ in S. cerevisiae and amino acid alignment of COQ5 homologs. (A) Thebenzoquinonehead groupofQ derives fromeither the 4HBor pABAaromatic ringprecursor, is
prenylated by Coq2 and further modiﬁed by Coq polypeptides to make the Q6-intermediate demethyl-demethoxy-hydroquinone (DDMQ6H2). Coq5 catalyzes the transfer of a methyl
group from AdoMet to the C2 position of the hydroquinone ring to make demethoxy-Q6 (DMQ6H2), which is ultimately converted into the fully substituted Q6H2. (B) Amino acid
alignments of COQ5 homologs were generated byMultAlin. In red are highly conserved residues, in blue, moderately conserved residues. Methyltransferase motifs [38,39] are designated
by the dashed-line boxes. The aligned sequences include: Homo sapiens COQ5 (84274), Mus musculus Coq5 (52064), Gallus gallus COQ5 (416975), Drosophila melanogaster CG2453
(32272), Arabidopsis thaliana AT5G57300 (835835), Caenorhabditis elegans COQ-5 (176099), Saccharomyces cerevisiae Coq5 (854930), and Escherichia coliUbiE (12932088). Single unique
nucleotide substitutions in coq5mutant alleles producing amino acid substitutions are designated by arrowheads (▼) on theﬁgure as G596A (G199D) for coq5-2, G911A (G304D) for coq5-
3, G279A (W93STOP) for coq5-4, and G361A (G121R) for coq5-5. S. cerevisiae Coq5 residues making contacts with S-adenosyl-L-methionine [35] are identiﬁed (red triangles). The yeast
DNA segment encoding the amino terminal 54 residues (underlined) replaced the corresponding segment of human COQ5 DNA to generate the hybrid yeast/human gene.
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COQ5 from different species. Northern blot analysis detected a single
human COQ5 transcript of about 1.5 kb expressed in all tissues tested
(Fig. 2A). Human COQ5 steady-state RNA levels were higher in liver,
lung, placenta, and skeletal muscle, similar to what was detected for
COQ6[23] (Fig.S1). RACE analysis on mRNA extracted from primary
skin ﬁbroblast detected a single transcription initiation site located
14 bp upstream of the ATG initiation codon, while the 3′ untranslated
region (UTR) extends to 501 nucleotides downstream of the termination
signal, and contains a non-canonical AGTAAA polyadenylation signal
(Fig. 2B). The size of the transcript corresponds to the hCOQ5 RNA
observed by Northern blot. There was no bioinformatics evidence
of COQ5 pseudogenes, or other genes with signiﬁcant similarity to
hCOQ5. A search of the human EST database showed evidence of a
second transcript that includes an additional 90 bp exon between
exon 1 and exon 2 (Fig. 2C). This exon contains a termination
codon so the predicted protein encoded by this transcript (which
we have termed COQ5 isoform 2) is only 70 aa. However, we didnot detect this transcript in RNA extracted from cultured skin ﬁbro-
blasts or skeletal muscle.
3.2. hCOQ5 encodes a mitochondrial matrix protein associated with hCOQ4
To determine the subcellular localization of human COQ5, we
transfected HeLa cells stably expressing mitochondrial-targeted RFP
[20] with a construct expressing a hCOQ5-GFP fusion protein. As seen
in Fig. 3A, the green and red ﬂuorescence signals coincide, indicating a
mitochondrial localization of hCOQ5. To determine the precise sub-
mitochondrial localization of hCOQ5, mitochondria prepared from
cultured HEK293 cells transfected with pCOQ5-myc were subjected
to treatment with proteinase K under different conditions (hypoton-
ic buffer to disrupt outer membrane, or triton X-100 to disrupt both
outer and inner membranes). Extracts were separated by SDS-PAGE
and immunoblot analyses were performed with antibodies recog-
nizing TOM20 (outer membrane protein), OPA1 (intermembrane
space), GRP75 (matrix enzyme) and COQ5Myc (Fig. 3B, Table 3). The
Fig. 2. Characterization of RNA steady-state levels, transcript isoforms, and gene structure
of human COQ5. (A) Northern blot analysis of COQ5 expression in different issues. Each
lane contains 200 ng of polyA+ mRNA. (B) Schematic structure of the principal transcript
of human COQ5 as determined by RACE experiments. (C) Genomic structure of the 5 ′
region of COQ5 showing the alternatively spliced exon 2b and the resulting proteins.
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ing that hCOQ5 is localized to the mitochondrial matrix, similar to the
GRP75 matrix marker.
To determine whether hCOQ5 is associated with the mitochondrial
inner membrane, mitochondrial extracts were treated with sonication,
sodium carbonate, or Triton X-100 (Fig. 3C). After treatment samples
were precipitatedwith TCA and centrifuged. Aliquots of the supernatant
and of the resuspended pelletswere then separatedwith SDS-PAGE and
polypeptides were detected with immune-blot analyses. Membranes
were assayedwith antibodies recognizing porin (an integralmembrane
protein), SDHA (a peripheral membrane protein), and COQ5Myc. The
association of hCOQ5 to the membrane is looser than SDHA, since soni-
cation itself partially released the protein (Fig. 3C). Overall these results
indicate that hCOQ5 is peripherally associated with the mitochondrial
inner membrane on the matrix side, and conﬁrm the ﬁndings of Chen
et al. [27].
In yeast, Coq4 is a crucial organizer of the CoQ-synthome, a multi-
subunit complex required for Q biosynthesis [8]. To determine the
association of COQ4 with COQ5 in human cells, we performed immune-
precipitation assays. Tagged versions of COQ4-V5 and COQ5-myc were
co-expressed inHEK293 cells. After cell harvesting,mitochondrial lysates
were immune-precipitated with either anti-V5 or anti-myc antibodies.
Immune-precipitates were separated by SDS-PAGE, and the proteinstransferred to a membrane that was then probed with antibodies to
the V5- or myc-epitopes. Fig. 3D shows that immune-precipitation of
COQ4-V5 captures COQ5-myc and vice versa, indicating that these COQ
proteins physically associate in a complex in human cells.
3.3. Expression of human or E. coli COQ5 homologs rescues yeast coq5Δ
mutants over-expressing COQ8
We examined if expression of hCOQ5 could complement the Q6
biosynthetic defect in coq5Δ mutant yeast. Human COQ5 expressed
from either low- or high-copy expression plasmids failed to rescue
growth of coq5Δ mutant yeast on medium containing glycerol as the
sole carbon source (Fig. 4 and data not shown). Human proteins are
sometimes not properly imported into yeast mitochondria [14,23].
Thus, a hybrid gene construct was prepared in which amino acids 1–55
of hCOQ5 were replaced with the ﬁrst 54 amino acids of S. cerevisiae
Coq5. This construct is referred to as yeast–human hybrid COQ5 or
yhCOQ5 (Table 2). As shown by a plate dilution assay, neither hCOQ5
nor yhCOQ5 rescues the growth of yeast coq5Δ on non-fermentable
YPGmedium (Fig. 4A). This result corroborates previous studies demon-
strating that expression of the E. coli Coq5 homolog, UbiE, also failed to
rescue growth of the yeast coq5Δmutant on YPG medium [16].
We therefore asked whether the problem could be related to a
failure of the human COQ5 protein to stabilize the Coq polypeptide
complex in yeast coq5Δ cells. Recent work has shown that the over-
expression of the putative Coq8 kinase in certain coq null mutants
allows synthesis of late-stage Q-intermediates, restores steady-state
levels of Coq polypeptides, and their association in a high molecular
mass complex known as the CoQ-synthome [8,10,28]. To examine
rescue of coq5Δ in the presence of the CoQ-synthome, yeast Coq8 was
over-expressed on a high copy plasmid (hcCOQ8) and strains were
grown on selective media (Fig. 4B). Co-expression of yeast Coq8 with
either yhCOQ5 or E. coli UbiE, both of which contain an amino-terminal
yeast mitochondrial leader sequence, rescues growth of coq5Δ on YPG
medium (Fig. 4B). The rescue by hCOQ5 is less robust, suggesting that a
yeast mitochondrial leader sequence is critical for efﬁcient import of
hCOQ5 into yeast mitochondria.
To examine Q6 levels, lipids were extracted from yeast cells and
subjected to HPLC and tandem mass spectrometry [10]. In the absence
of yeast Coq8 over-expression, Q6 was not detected in any of the coq5Δ
mutant yeast strains (Fig. 4C). However, in the presence of yeast Coq8
over-expression, theQ6 content is partially restored in strains expressing
E. coli UbiE, yhCOQ5, or hCOQ5 (Fig. 4C). These results indicate that
human and E. coli Coq5 homologs can rescue the defect in the yeast
coq5Δ mutant only when other yeast Coq polypeptides are stabilized
by Coq8 over-expression.
3.4. Expression of human and E. coli COQ5 homologs partially restores
Q6-content in coq5-2 and coq5-5 point mutants
To further examinewhether expression of human COQ5 homologs is
able to rescue coq5 mutant strains retaining a stable CoQ-synthome,
yeast coq5 strains with point mutations within or adjacent to one
of the methyltransferase motifs were employed (Fig. 1B). Two point mu-
tants, coq5-2 (CH83-B3) and coq5-5 (CH316-6B) lackC-methyltransferase
activity and Q6 biosynthesis but retain steady state levels of Coq5 and
other Coq polypeptides [15,16,29]. Expression of E. coli UbiE, hCOQ5
or yhCOQ5 in these yeast coq5 point mutants rescued growth on rich
glycerol (YPG) medium and partially restored Q6 content (Fig. 5).
Expression of hCOQ5 results in detectable growth in the coq5-5
mutant on respiratory media even though the content of Q6 ranges
from 0.4% to 3% of wild-type Q6 content (Fig. 5C). Serial plate dilution
assays show that growth on respiratory medium requires only a small
amount of Q6, as restoration of a low Q6 content is sufﬁcient to rescue
plate growth of the coq5-2 and coq5-5 point mutants (Fig. 5).
Fig. 3. Human COQ5 is located within the mitochondrial matrix and is peripherally associated with the inner membrane. (A) Co-localization of COQ5-GFP fusion proteins transiently
expressed from pCOQ5-GFP in HeLa cells stably expressing mitochondria targeted RFP (mtRFP). (B) Proteinase K (PK) protection assays. Mitochondria were subjected to PK treatment
directly after isolation and only outer membrane proteins are degraded (e.g. TOM20). Alternatively, mitochondria were treated with PK after treatment with hypotonic solution, which
causes swelling (SW), and renders proteins of the inter-membrane space (e.g. OPA1) accessible to PK; or after treatment with a detergent (Triton X-100) which disrupts all mitochondrial
membranes and allows PK degradation of all compartments including matrix proteins (e.g. GRP75). The susceptibility of COQ5 to PK follows the same pattern as GRP75, a mitochondrial
matrix protein. (C) Membrane association assays. Mitochondrial membranes were prepared by sonication followed by centrifugation (12,000 g for 10 min) to generate pellet and
supernatant fractions: isotonic buffer conditions (SON), NaCO3 treatment (which solubilizes peripheral membrane proteins), or Triton X-100 (which solubilizes integral membrane
proteins). Aliquots of the supernatants (S) and pellets (P) were separated by SDS-PAGE and proteins were detected with the designated antibodies. A sample of the total membrane
preparation (T) was included as control. (D) Mitochondrial extracts of HEK293 cells co-expressing COQ5-myc and COQ4-V5 were immune-precipitated with anti-myc, anti-V5 or with
pre-immune sera. Immune-precipitates were separated by SDS-PAGE, transferred to membranes and the tagged-polypeptides were detected with either anti-V5 or anti-myc antibodies.
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de novo Q6 biosynthesis and accumulation of Q6-intermediates
The Q6 levelsmeasured in Figs. 4C and 5C account for total content of
Q6 present at the time of harvest; to assay the ability of mutants to
synthesize new Q6 de novo, coq5-5 point mutants harboring hCOQ5 orYPD SD-Ura Y
YPD SD-Ura-Leu Y
yCOQ5 + hcCOQ8
hCOQ5 + hcCOQ8
yhCOQ5 + hcCOQ8
Vector + hcCOQ8
WT W3031A
UbiE + hcCOQ8
W303Δ COQ5
A
yCOQ5
hCOQ5
yhCOQ5
Vector
WT W3031A
UbiE
W303Δ COQ5
B
Fig. 4. COQ5 homologs partially restore growth on respiratory medium and Q6-content in yea
transformed with the designated plasmids without (A) or with (B) a high copy COQ8 plasmid
0.2 optical density (OD), and 2 μl of 1:5 serial dilutions was spotted onto plate media. Plate
0.2 OD and collected after 4.5 h. Q6 content in cell lipid extracts was determined by HPLC/MS
of four measurements from two independent samples each with two injections. Error bars repyhCOQ5 were grown in medium containing either 13C6-pABA or
13C6-4HB. pABA and 4HB are two aromatic ring precursors of yeast Q6
biosynthesis, and inclusion of 13C6-pABA or 13C6-4HB will result in the
new synthesis of 13C6–Q6 detectable by its additionalmass of+6 indicat-
ing the incorporation of a 13C6-label. The yeast coq5-5 point mutant
rescued with either hCOQ5 or yhCOQ5 was able to synthesize similarPG
PG
C
Empty vector hcCOQ8
coq5Δ
st coq5 null mutants over-expressing COQ8. Yeast coq5 null mutants (W303ΔCOQ5) were
(hcCOQ8). Each mutant strain was cultured overnight in SD-selective media, adjusted to
s are depicted after 3 days of incubation at 30 °C. (C) Yeast were seeded in SD–Ura at
–MS as described [10] with a limit of detection of 10 fmol/μl. Each bar represents a total
resent standard deviations.
AB
yCOQ5
hCOQ5
yhCOQ5
Vector
WT W3031A
UbiE
coq5-2
yCOQ5
hCOQ5
yhCOQ5
Vector
WT W3031A
UbiE
coq5-5 YPD SD-Ura YPG
CYPD SD-Ura YPG
Fig. 5.COQ5homologs partially restore growth on respiratorymediumandQ6-content in yeast coq5 pointmutants. (A and B) Yeastwere seeded in SD–Ura at 0.2ODand collected after 3 h
for Q6 analysis and plate dilution assays. Plates are depicted after 3 days of incubation at 30 °C. (C)Q6 content in cell lipid extractswasdeterminedbyHPLC/MS–MSasdescribed [10]. Limit
of detection was 50 amol/μl. Each bar represents a total of four measurements from two independent samples each with two injections. Error bars represent standard deviations.
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(Fig. 6B). However, the Q6 synthesis was much less efﬁcient as com-
pared to either wild-type yeast or to the coq5-5 mutant rescued by
yeast COQ5.
The low content of newly synthesized 13C6–Q6 in the yeast coq5-5
point mutants expressing hCOQ5 or yhCOQ5 suggested that
Q 6-intermediates might accumulate in these strains. To determine
this, lipid extracts were examined for the presence of 13C6–Q6 interme-
diates. Of particular interest is the substrate of Coq5, demethyl-
demethoxy-Q6 (DDMQ6) (Fig. 1A). DDMQ6 was ﬁrst detected in
coq5Δ strains over-expressing Coq8 [10]. DDMQ6 is not detected in
wild-type yeast, presumably because it is quickly methylated in the
production of Q6. We therefore determined whether DDMQ6 could be
detected in strains with less efﬁcient Q6 biosynthesis, for example in
yeast coq5-5mutants expressing hCOQ5 or yhCOQ5.
The yeast coq5-5 mutant harboring yhCOQ5 was cultured in the
presence of 13C6-pABA. Lipid extracts were prepared and subjected to
reversed phase HPLC–MS/MS as described (Section 2.8). In extracts
prepared from 13C6-pABA-labeled yeast cells, a predicted precursor-to-Fig. 6. COQ5 homologs partially restore de novo Q6 content of yeast coq5-5mutants. Yeast cells w
After a 10-h incubation with label at 30 °C, 13C6–Q6 lipid extracts were determined by HPLC/MS–
from one sample. Error bars represent standard deviations.product ion transition for 13C6-labeled DDMQ6 eluted at 4.69 min. The
fragmentation spectrum (Fig. 7) revealed the 13C6-DDMQ6 [M + H]+
precursor ion, the 13C6-DDMQ6 tropylium product ion [M]+, and the
13C6-DDMQ6 chromenylium product ion [M]+.
The levels of the DDMQ6 and demethoxy-Q6 (DMQ6) were next ex-
amined in yeast coq5mutants expressing yhCOQ5 or E. coliUbiE (Fig. 8).
DMQ6 is detected in Q6-producing yeast strains characterized so far and
is a reﬂection of the Q6-content [30]. In mutants rescued by yeast COQ5
(blue trace in Fig. 8), DMQ6 is detected, but not DDMQ6, suggesting that
yeast Coq5 efﬁciently methylates DDMQ6 to make DMQ6. In contrast,
the yeast coq5-5 mutant harboring the empty vector control accumu-
lates DDMQ6 (gray trace in Fig. 8A and C) but DMQ6 is not detected
(gray trace, Fig. 8B and D). Notably, coq5-5 mutants harboring either
yhCOQ5 or UbiE accumulate DDMQ6 but also make small amounts
of DMQ6 (green and red traces, Fig. 8). We reason that the expression
of yhCOQ5 or UbiE results in slower, less efﬁcient methylation
of DDMQ6, leading to an accumulation of DDMQ6 and lower levels
DMQ6. These data indicate that in this system yhCOQ5 is less efﬁcient
than yCOQ5 as a C-methyltransferase.ere seeded at 0.07 OD into DODmedium supplemented with (A) 13C6-pABA or (B) 13C6-4HB.
MS as in [10] with a limit of detection of 10 fmol/μl. Each bar represents two measurements
OH
H3CO
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+
HO
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Fig. 7. Identiﬁcation of de novo demethyl-demethoxy-Q6 (DDMQ6) in lipid extracts of coq5-5:yhCOQ5 yeast cells. 13C6-DDMQ6was detected in the lipid extracts of coq5-5:yhCOQ5 cells grown
in the presence of 13C6-pABA as described in Materials and methods (Section 2.8). The 13C6-DDMQ6 [M+ H]+ precursor ion (13C612C31H55O3+; monoisotopic mass 553.4), the 13C6-DDMQ6
tropylium product ion [M]+ (13C612C2H9O3+; monoisotopic mass 159.05), and the 13C6-DDMQ6 chromenylium product ion [M]+ (13C612C5H13O3+; monoisotopic mass 199.1) are consistent
with the presence of 13C6-aromatic ring label as denoted by red asterisks.
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mass complex
The lower methyltransferase efﬁciency of the human and yeast–
human COQ5 orthologs elicits an interesting question:what interaction,
if any, do COQ5 orthologs have with the yeast CoQ-synthome? We
probed this question in a preliminary way by determining whether
the human COQ5 polypeptide co-migrated with yeast Coq polypeptides
at high molecular mass. Previous studies have shown that the Coq9
polypeptide co-puriﬁeswith other yeast Coq polypeptides andmigrates
at highmolecularmass in solubilized extracts of mitochondria [9]. Here,
the antibody against yeast Coq9 was used as a benchmark for the
presence of high molecular mass CoQ-synthome [8–10].
Mitochondria were puriﬁed from wild-type yeast and from coq5Δ
mutants over-expressing yeast Coq8 in combination with yhCOQ5,
yeast Coq5, or empty vector, and the digitonin extracts were separated
by 2D-BN-SDS/PAGE. We used a polyclonal antibody against hCOQ5
that identiﬁed yhCOQ5 expressed in the yeast coq5Δ mutant (Fig. S2).
The yhCOQ5 polypeptide was detected at high molecular mass
(~650 kDa), although most of the signal was observed in a broad
region around 66 kDa (Fig. 9A). Yeast Coq9 was also found tomigrate
with a pattern similar to the yhCOQ5 polypeptide on the same immune-
blot membrane (Fig. 9A). In the coq5Δ strain co-expressing high copy
yeast Coq8 and yeast Coq5, the yeast Coq5 polypeptide was detected at
high molecular mass complex together with yeast Coq9 (~300 kDa)
(Fig. 9B). Both yeast Coq5 and Coq9 were also present at lower mass
(Fig. 9B). In the coq5Δ strain co-expressing high copy yeast Coq8 andvector control, no Coq5 is detected, while Coq9 is observed at both low
and high molecular weight (Fig. 9C). In wild-type yeast Coq9 is present
across a wide range of high molecular mass complexes, while Coq5 is
present mainly in a broad region around 66 kDa, perhaps indicating
the presence of Coq5 and Coq9 in sub-complexes.4. Discussion
COQ5 encodes an essential protein involved in the biosynthetic
pathway of Q6 in S. cerevisiae. It is the only known C-methyltransferase
enzyme involved in Q6 synthesis, and catalyzes the methylation
of demethyl-demethoxy-Q6H2 (DDMQ6H2) to form demethoxy-Q6H2
(DMQ6H2). In yeast, Coq5 and several COQ gene products are associated
in the CoQ-synthome, a high molecular mass complex peripherally asso-
ciated with the matrix side of the mitochondrial inner membrane [8]. In
this study, we conﬁrmed that the human protein is localized to the mito-
chondrialmatrix and is peripherally associatedwith the innermembrane.
We also showed that hCOQ5 physically associateswith hCOQ4, indicating
that a COQ multi-enzyme complex is also present in human cells.
Human COQ5RNAwas expressed ubiquitously in humanorgan sam-
ples as assayed by Northern blotting (Fig. 3). Steady state RNA levels for
COQ2, COQ4, and COQ6 have been determined for a variety of human
tissues [20,23,31]. In comparing the expression levels of these COQ
genes, there does not seem to be a common pattern: COQ5 had the
highest expression levels in the placenta, liver, skeletal muscle, and
lung, COQ6 in skeletal muscle, kidney, and placenta, COQ2 in skeletal
Fig. 8.Yeast coq5mutants rescuedwith COQ5 homologs accumulate Q6-intermediate DDMQ6. The designated yeast coq5mutants were seeded in selective SDmediumat 0.2 OD, collected
after 3 h, and lipidswere extracted for Q6 analysis.MRMdetectedprecursor-to-product ion transition 547.4/153.1 (DDMQ6) inpanels (A) and (C); andprecursor-to-product ion transition
561.4/167.0 (DMQ6) in panels (B) and (D). Red trace indicates the presence of the yeast-human hybrid COQ5, blue trace indicates yeast COQ5, green indicates E. coli UbiE, and gray
indicates the empty vector control.
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and pancreas.
A search of the EST database revealed a possible second transcript
encoding a truncated form of COQ5. The presence of transcripts
encoding non-functional proteins is not unusual for COQ genes and
has been reported also for PDSS2, COQ4, and COQ6[20,23,32]. The
functional signiﬁcance of the truncated proteins is still unclear, although
they could play a regulatory role [33].
Despite a relatively high degree of homology to its yeast counterpart,
the human COQ5 protein failed to complement yeast mutants with
a deletion in COQ5, as determined by a lack of growth on non-
fermentable carbon source and absence of Q 6. Rescue by human
COQ5 was more efﬁcient when the protein contained an appended
S. cerevisiae Coq5 mitochondrial leader sequence. However, even
under this condition, rescue was observed only in (1) yeast coq5 point
mutants harboring stable but catalytically inactive Coq5 polypeptide,
or (2) yeast coq5 null mutants over-expressing COQ8. We note that
both conditions permit the stabilization of CoQ-synthome required for
Q6 biosynthesis in yeast. The results here suggest that COQ5 orthologs
can serve as functional C-methyltransferases and restore Q biosynthesis
in the yeast coq5mutants only when the other yeast Coq polypeptides
are preserved.
Interestingly, the expression of human COQ5was recently shown to
complement a Schizosaccharomyces pombe coq5Δ mutant for growth
in medium containing a nonfermentable carbon source [34]. Unlike
the S. cerevisiae coq5Δ mutant, the S. pombe coq5Δ mutant contained
peaks tentatively identiﬁed as late-stage Q-intermediates, suggesting
that the S. pombe coq deletion mutants do not have the same drastic
“early intermediate” phenotype as observed in the S. cerevisiae coq dele-
tionmutants. Indeed, human COQhomologswere shown to rescue each
of the S. pombe coq deletion mutants, with the exception of Coq9 [34].For both S. pombe and S. cerevisiae, expression of human COQ5 results
in production of a very small amount of Q, as compared to wild-type
cells. Several interspeciﬁc complementation studies suggest that such
rescue of yeast growth on nonfermentable carbon sources can be
accomplished with less than 0.2% of the normal levels of Q [14,23].
Yeast coq5-5 mutants rescued by yeast Coq5 are able to efﬁciently
methylate DDMQ6H2 to make DMQ6H2 and high amounts of Q6H2.
Due to autoxidation, the DDMQ6 and DMQ6 quinones are the predom-
inant forms recovered in lipid extracts. In contrast, the accumulation of
the Coq5 substrate DDMQ6 in yeast coq5-5 mutants expressing either
human COQ5 or E. coli UbiE indicates a slower or less efﬁcient methyla-
tion of DDMQ6H2, and is also consistent with the lower levels of both
DMQ6 and Q6. A recent crystal structure of the S. cerevisiae Coq5 poly-
peptide showed the structure to be a dimer, and identiﬁed amino acid
residues at the dimer interface domain [35]. The residues at the yeast
Coq5 dimer interface are not as highly conserved between Coq5 homo-
logs as the active-site residues that contact S-adenosyl-L-methionine
[35]. We speculate that the interaction of the yeast Coq5 dimer with
the yeast CoQ-synthome enhances the catalytic efﬁciency of the C-
methylation, and that the partial rescue observed by the heterologous
COQ5 polypeptides results from a less efﬁcient or absence of interaction
with the yeast CoQ-synthome.
To explore this idea we examined whether the human COQ5 homo-
log might interact with the yeast CoQ-synthome as determined by
separation of digitonin solubilized mitochondrial extracts with 2D-BN-
SDS/PAGE. Small amounts of the hCOQ5 polypeptide were observed at
high molecular mass in the coq5 null mutant harboring yhCOQ5 with
Coq8 over-expression. Similarly, small amounts of the yeast Coq5
polypeptidewere observed at highmolecular mass in the coq5 null mu-
tant harboring yeast COQ5with Coq8 over-expression. This may be due
to the presence of over-expressed Coq8. However, we did not detect
Coq9
669 440 232 140 66 kDaWT Mito 
ΔCOQ5:8:yhCOQ5
Human
COQ5
Coq9
669 440 232 140 66 kDaWT Mito 
ΔCOQ5:8:yCOQ5
669 440 232 140 66 kDaWT Mito 
Coq5
Coq9
ΔCOQ5:8:vector
WT W3031A
Coq5
Coq9
669 440 232 140 66 kDaWT Mito 
Coq5
Coq9
Coq5
A
B
C
D
Fig. 9.Human COQ5 polypeptide co-migrates with yeast Coq9 at highmolecular mass. Puriﬁedmitochondria (200 μg of protein) from the designated yeast strains were separated by 2D-
BN-SDS/PAGE, and the membranes containing transferred proteins were probed with antibodies against human COQ5, yeast Coq9 or yeast Coq5. Mitochondria were isolated from coq5
null with co-expression of Coq8 (hcCOQ8) and (A) yhCOQ5, (B) yCOQ5 and (C) empty vector. (D), Mitochondria were puriﬁed from wild-type yeast, W3031A. A sample of wild-type
mitochondria separated just in the SDS-second dimension served as a positive control and is designated as WT Mito. The positions of molecular mass standards in the ﬁrst dimension
are indicated at the top of each panel.
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mass in mitochondria prepared from wild-type yeast cells (Fig. 9D and
unpublished results). It is very challenging to recover the intact CoQ-
synthome. The complex must be ﬁrst solubilized from the inner mito-
chondrial membrane with detergent, and depending on the separation
conditions, may behave very differently. For example, althoughwe read-
ily detect the presence of the Coq5 polypeptide in complexes captured
with tagged forms of Coq9 [9], only very small amounts of Coq5 are
detected at highmolecularmass by 2D-blue native-SDS PAGE [8]. Tauche
et al. observed a Coq3–Coq5–Coq9 complex with myc-tagged Coq
polypeptides [36]. We do not always observe the Coq5 polypeptide at
high molecular mass when separated by size exclusion chromatography
[37]. Based on these observationswe think that it is very likely that Coq5
readily dissociates from the CoQ synthome. Obviously, the absence of co-
migration does not rule out the possibility of a transient orweak physical
association.
A physical interaction between the human COQ5 and the yeast Coq
polypeptide complex may not be necessary for partial rescue of Q6
content. The CoQ-synthome needs only to provide human COQ5 with
its substrate DDMQ6H2, which may be accomplished with human COQ5
peripherally associated with the complex. Low Q6 content and the
presence of Q6-intermediates suggest either inefﬁcient or weak in-
teraction with the Coq complex. The results presented here suggest
that human and E. coli Coq5 homologs expressed in yeast retain C-methyltransferase function, but rescue the yeast coq5 mutants only
in the presence of the assembled yeast CoQ-synthome.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbalip.2014.08.007.Acknowledgements
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